377 related articles for article (PubMed ID: 27472865)
1. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
[TBL] [Abstract][Full Text] [Related]
2. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.
Indrawattana N; Sookrung N; Kulkeaw K; Seesuay W; Kongngoen T; Chongsa-nguan M; Tungtrongchitr A; Chaicumpa W
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):85-93. PubMed ID: 20527521
[TBL] [Abstract][Full Text] [Related]
3. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
[TBL] [Abstract][Full Text] [Related]
4. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.
Yousefi M; Tahmasebi F; Younesi V; Razavi A; Khoshnoodi J; Bayat AA; Abbasi E; Rabbani H; Jeddi-Tehrani M; Shokri F
J Immunotoxicol; 2014; 11(1):28-34. PubMed ID: 23369087
[TBL] [Abstract][Full Text] [Related]
5. Production of Recombinant Human scFv Against Tetanus Toxin Heavy Chain by Phage Display Technology.
Khalili E; Lakzaei M; Rasaee MJ; Aminian M
Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):303-9. PubMed ID: 26492617
[TBL] [Abstract][Full Text] [Related]
6. Construction of scFv library of human antibodies against tetanus toxin.
Nejad HR; Mehrabadi JF; Nourozi J; Mahdavi M
Hum Antibodies; 2014; 23(1-2):21-6. PubMed ID: 25812699
[TBL] [Abstract][Full Text] [Related]
7. Novel neutralizing human monoclonal antibodies against tetanus neurotoxin.
Minamitani T; Kiyose K; Otsubo R; Ito T; Akiba H; Furuta RA; Inoue T; Tsumoto K; Satake M; Yasui T
Sci Rep; 2021 Jun; 11(1):12134. PubMed ID: 34108521
[TBL] [Abstract][Full Text] [Related]
8. Tetanus vaccine-induced human neutralizing antibodies provide full protection against neurotoxin challenge in mice.
Zhang G; Yu R; Chi X; Chen Z; Hao M; Du P; Fan P; Liu Y; Dong Y; Fang T; Chen Y; Song X; Liu S; Li J; Yu C; Chen W
Int Immunopharmacol; 2021 Feb; 91():107297. PubMed ID: 33360088
[TBL] [Abstract][Full Text] [Related]
9. Epitope Mapping of Tetanus Toxin by Monoclonal Antibodies: Implication for Immunotherapy and Vaccine Design.
Ghotloo S; Golsaz-Shirazi F; Amiri MM; Jeddi-Tehrani M; Shokri F
Neurotox Res; 2020 Feb; 37(2):239-249. PubMed ID: 31410686
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of a neutralizing murine monoclonal antibody against tetanus toxin.
Li Y; Chen Y; Cui J; Liu D; Zhang W; Xue C; Xiong X; Liu G; Chen H
J Immunol Methods; 2023 Feb; 513():113427. PubMed ID: 36652969
[TBL] [Abstract][Full Text] [Related]
11. A conformational change of C fragment of tetanus neurotoxin reduces its ganglioside-binding activity but does not destroy its immunogenicity.
Yu R; Yi S; Yu C; Fang T; Liu S; Yu T; Song X; Fu L; Hou L; Chen W
Clin Vaccine Immunol; 2011 Oct; 18(10):1668-72. PubMed ID: 21813664
[TBL] [Abstract][Full Text] [Related]
12. Relation between protective potency and specificity of antibodies in sera of tetanus immunized individuals.
German-Fattal M; German A; Bizzini B
Eur J Epidemiol; 1987 Jun; 3(2):119-22. PubMed ID: 3301392
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing anti-diphtheria toxin scFv produced by phage display.
Khalili E; Lakzaei M; Aminian M
Biotechnol Lett; 2024 Jun; 46(3):385-398. PubMed ID: 38607601
[TBL] [Abstract][Full Text] [Related]
14. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 2. Antibody production in lymphocyte cultures].
Jahn S; Kiessig ST; Grunow R; von Baehr R
Allerg Immunol (Leipz); 1987; 33(2):89-94. PubMed ID: 2959130
[TBL] [Abstract][Full Text] [Related]
15. Tetanus neurotoxin HCC protein commits T cells to IFN-γ producing cells.
Torabi Goudarzi S; Hajivalili M; Hosseini M; Ghafari Khamene M; Yazdani Y; Sadreddini S; Miahipour A; Younesi V; Yousefi M
Cell Mol Biol (Noisy-le-grand); 2016 Mar; 62(3):20-4. PubMed ID: 27064869
[TBL] [Abstract][Full Text] [Related]
16. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 1. Systems for the detection of in vitro synthetized specific immunoglobulins. Strategies of test development].
Kiessig ST; Jahn S; Porstmann T; von Baehr R
Allerg Immunol (Leipz); 1987; 33(2):79-87. PubMed ID: 2959129
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus vaccine candidate.
Yu R; Hou L; Yu C; Liu S; Ren J; Fang T; Zhang X; Chen W
Immunobiology; 2011 Apr; 216(4):485-90. PubMed ID: 20888666
[TBL] [Abstract][Full Text] [Related]
18. Construction of human anti-tetanus single-chain variable fragment applying SYMPLEX technology.
Esmati L; Mehrabadi JF; Bazaz M; Nejad HR
Hum Antibodies; 2016; 24(3-4):77-83. PubMed ID: 27792006
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin.
Liu XY; Wei DK; Li ZY; Lu JS; Xie XM; Yu YZ; Pang XB
Vaccine; 2023 Nov; 41(46):6834-6841. PubMed ID: 37816654
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against tetanus toxin and toxoid.
Ahnert-Hilger G; Bizzini B; Goretzki K; Müller H; Völckers C; Habermann E
Med Microbiol Immunol; 1983; 172(2):123-35. PubMed ID: 6193402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
